1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
0 |
| Hold |
3 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | - |
| Net profit | -2.22M | 14.94% |
| EBITDA | -2.26M | 56.78% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €2.04M |
Number of shares | 4.51M |
52-week high/low | €1.25 - €0.41 |
| Dividends | No |
Beta | 1.24 |
P/E ratio | -0.15 |
PEG ratio | 0.00 |
P/B ratio | 0.63 |
P/S ratio | 0.00 |
Company profile
| Name | Oragenics Inc |
| CEO | Janet Huffman |
| Employees | 3 |
Discover assets
Shareholders of Oragenics Inc also invest in the following assets
